Sitagliptin/Metformin Glenmark (Metformin Hydrochloride, Sitagliptin)

Sitagliptin/Metformin Glenmark combines two diabetes medications to improve blood sugar control. This oral tablet is prescribed alongside diet and exercise for type 2 diabetes management. It helps regulate glucose levels by enhancing insulin production and reducing liver sugar output. Suitable for adults with type 2 diabetes seeking combined therapy.

Sitagliptin/Metformin Glenmark is used to improve blood sugar levels in adults with type 2 diabetes. It combines sitagliptin, a DPP-4 inhibitor, with metformin, a biguanide, to support better glycemic control. This medication is typically prescribed when diet and exercise alone are insufficient. It may be used alongside other diabetes treatments as directed by a healthcare provider.

This combination medication helps stabilize blood sugar throughout the day by supporting the body’s natural insulin response. Users may notice improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Some people experience mild digestive changes as their body adjusts to the medication.

Store Sitagliptin/Metformin Glenmark at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications and supplements you take before starting this treatment. Regular blood sugar monitoring is recommended while using this medication.

Sitagliptin/Metformin Glenmark may interact with alcohol, increasing the risk of lactic acidosis. Certain medications, such as diuretics or corticosteroids, can affect blood sugar levels when taken with this combination. Always consult a healthcare provider before combining with other drugs, including over-the-counter products and herbal supplements.